Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis

BOZ C., TERZİ M., Ozer B., Turkoglu R., KARABUDAK R., EFENDİ H., ...More

MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol.36, 2019 (SCI-Expanded) identifier identifier identifier


Background: Fingolimod and teriflunomide are commonly used in the treatment of relapsing-remitting multiple sclerosis (RRMS). These have not been compared in controlled trials, but only in observational studies, with inconclusive results. Comparison of their effect on relapse and disability in a real-world setting is therefore needed.